4,666
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Effective topical delivery systems for corticosteroids: dermatological and histological evaluations

, , , , , , , , & show all
Pages 1502-1513 | Received 11 Jul 2014, Accepted 29 Aug 2014, Published online: 26 Sep 2014

References

  • Benson HAE. (2005). Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv 2:23–33
  • Brugè F, Damiani E, Puglia C, et al. (2013). Nanolipid carriers loaded with CoQ10: effect on human dermal fibroblasts under normal and UVA-mediated oxidative conditions. Int J Pharm 455:348–56
  • Choi MJ, Maibach HI. (2005). Liposomes and niosomes as topical drug delivery systems. Skin Pharmacol Physiol 18:209–19
  • Cronstein BN, Kimmel SC, Levin RI, et al. (1992). A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA 89:9991–5
  • de Leeuw J, de Vijlder HC, Bjerring P, Neumann HAM. (2009). Liposomes in dermatology today. Discusses the characteristics of liposome formulations, a synopsis of the state of liposome research and how liposomal formulations are impacting the field of dermal drug delivery. J Eur Acad Dermatol 23:505–16
  • Egbaria K, Ramachandran C, Weiner N. (1990). Topical delivery of ciclosporin: evaluation of various formulations using in vitro diffusion studies in hairless mouse skin. Skin Pharmacol 3:21–8
  • El Maghraby GM, Barry BW, Williams AC. (2008). Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci 34:203–22
  • Fattal E, Rojas J, Roblot-Treupel L, et al. (1991). Ampicillin-loaded liposomes and nanoparticles: comparison of drug loading, drug release and in vitro antimicrobial activity. J Microencapsul 8:29–36
  • Fresta M, Puglisi G. (1997). Corticosteroid dermal delivery with skin-lipid liposomes. J Control Release 44:141–51
  • Gabrijelčič V, Šentjurc M. (1995). Influence of hydrogels on liposome stability and on the transport of liposome entrapped substances into the skin. Int J Pharm 118:207–12
  • Gautam A, Singh D, Vijayaraghavan R. (2011). Dermal exposure of nanoparticles: an understanding. J Cell Tissue Research 11:2703–8
  • Gokce EH, Korkmaz E, Dellera E, et al. (2012). Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. Int J Nanomedicine 7:1841–50
  • Honeywell-Nguyen PL, Bouwstra JA. (2005). Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today Technol 2:67–74
  • Ishii H, Fujino K, Todo H, Sugibayashi K. (2012). Evaluation of the skin blanching of topically applied steroids using a Chroma meter in animals. Exp Anim 6:147–56
  • Jung SH, Cho YS, Jun SS, et al. (2011). Topical application of liposomal cobalamin hydrogel for atopic dermatitis therapy. Pharmazie 66:430–5
  • Kang MJ, Eum JY, Park SH, et al. (2010). Pep-1 peptide-conjugated elastic liposomal formulation of taxifolin glycoside for the treatment of atopic dermatitis in NC/Nga mice. Int J Pharm 402:198–204
  • Kawakami T, Ando T, Kimura M, et al. (2009). Mast cells in atopic dermatitis. Curr Opin Immunol 21:666–78
  • Kircik LH. (2012). Transepidermal water loss (TEWL) and corneometry with hydrogel vehicle in the treatment of atopic dermatitis: a randomized, investigator-blind pilot study. J Drugs Dermatol 11:180–4
  • Lei W, Yu C, Lin H, Zhou X. (2013). Development of tacrolimus-loaded transfersomes for deeper skin penetration enhancement and therapeutic effect improvement in vivo. AJPS 8:336–45
  • Liu J, Hu G. (2007). Advances in studies of phospholipids as carriers in skin topical application. JNMU 21:349–53
  • Mura P, Maestrelli F, Gonzalez-Rodriguez ML, et al. (2007). Development, characterization and in vivo evaluation of benzocaine-loaded liposomes. Eur J Pharm Biopharm 67:86–95
  • Naderkhani E, Erber A, Škalko-Basnet N, Flaten GE. (2014). Improved permeability of acyclovir: optimization of mucoadhesive liposomes using the phospholipid vesicle-based permeation assay. J Pharm Sci 103:661–8
  • Nojima H, Carstens E. (2003). 5-Hydroxytryptamine (5-HT)2 receptor involvement in acute 5-HT-evoked scratching but not in allergic pruritus Induced by dinitrofluorobenzene in rats. J Pharmacol Exp Ther 306:245–52
  • Ozcan I, Azizoglu E, Senyigit T, et al. (2013a). Comparison of PLGA and lecithin/chitosan nanoparticles for dermal targeting of betamethasone valerate. J Drug Target 21:542–50
  • Ozcan I, Azizoglu E, Şenyigit T, et al. (2013b). Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations. Int J Nanomedicine 8:461–75
  • Paudel KS, Milewski M, Swadley CL, et al. (2010). Challenges and opportunities in dermal/transdermal delivery. Ther Deliv 1:109–31
  • Pavelic Z, Skalko-Basnet N, Jalsenjak I. (2005). Characterisation and in vitro evaluation of bioadhesive liposome gels for local therapy of vaginitis. Int J Pharm 301:140–8
  • Pople PV, Singh KK. (2010). Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis. Int J Pharm 398:165–78
  • Reis CP, Jeronimo AR, Pinto P, et al. (2013). Hydrocortisone acetate-loaded PCL nanoparticles as an innovative dermatological therapy for atopic dermatitis. Biomed Biopharm Res 10:73–82
  • Requena L, Cerroni L, Kutzner H. (2012). Histopathologic patterns associated with external agents. Dermatol Clin 30:731–48
  • Rosado C, Silva C, Reis CR. (2013). Hydrocortisone-loaded poly(ε-caprolactone) nanoparticles for atopic dermatitis treatment. Pharm Dev Technol 18:710–18
  • Santos Maia C, Mehnert W, Schaller M, et al. (2002). Drug targeting by solid lipid nanoparticles for dermal use. J Drug Target 10:489–95
  • Schleyerbach R, Weithmann KU, Barlett R. (2002). Analgesic, anti-inflammatory and anti-pyretic activity. In: Vogel HG, ed. Drug discovery and evaluation; pharmacological assays. Berlin Heidelberg, New York: Springer-Verlag, 983–1115
  • Senyigit T, Ozcan I, Ozer O. (2012). Innovative topical formulations for treatment of dermatitis. Recent Pat Inflamm Allergy Drug Discov 6:186–201
  • Sezer AD, Bas AL, Akbuga J. (2004). Encapsulation of enrofloxacin in liposomes I: preparation and in vitro characterization of LUV. J Liposome Res 14:77–86
  • Shivhare UD, Ambulkar DU, Mathur VB, et al. (2009). Formulation and evaluation of pentoxifylline liposome formulation. Dig J Nanomater Bios 4:857–62
  • Sinico C, Manconi M, Peppi M, et al. (2005). Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle–skin interaction. J Control Release 103:123–36
  • Tan Q, Liu W, Guo C, Zhai G. (2011). Preparation and evaluation of quercetin-loaded lecithin-chitosan nanoparticles for topical delivery. Int J Nanomedicine 6:1621–30
  • Upadhyay SU, Patel JK, Patel VA, Saluja AK. (2012). Effect of different lipids and surfactants on formulation of solid lipid nanoparticles incorporating tamoxifen citrate. J Pharm Bioallied Sci 4:112–13
  • van Kuijk-Meuwissen ME, Mougin L, Junginger HE, Bouwstra JA. (1998). Application of vesicles to rat skin in vivo: a confocal laser scanning microscopy study. J Control Release 56:189–96
  • Wu G, Li L, Sung GH, et al. (2011). Inhibition of 2,4-dinitrofluorobenzene-induced atopic dermatitis by topical application of the butanol extract of Cordyceps bassiana in NC/Nga mice. J Ethnopharmacol 134:504–9
  • Zhang H, Wang ZY, Gong W, et al. (2011). Development and characteristics of temperature-sensitive liposomes for vinorelbine bitartrate. Int J Pharm 414:56–62

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.